Preview

Rational Pharmacotherapy in Cardiology

Advanced search

New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer)

Full Text:

Abstract

.

About the Author

Article Editorial

Russian Federation


References

1. Coleman CI, Antz M, Simard E, et al. Real-world evidence of stroke prevention in patients with nonvalvular atrial fibrillation in the United States: the REVISIT-US study. Oral Presentation at ECAS 2016. 17 April 2016.

2. Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation. New Eng J Med 2011;365:883-91.


For citation:


New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer). Rational Pharmacotherapy in Cardiology. 2016;12(4):487-488. (In Russ.)

Views: 148


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)